# EDGAR Filing Document

**Accession Number:** 0001713863
**File Stem:** 0001213900-25-052707
**Filing Date:** 2025-6
**Character Count:** 10543
**Document Hash:** 1b8207058c4d41c9cb1fa6f20a09c569
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-052707.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0001213900-25-052707

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Rafael Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001713863
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 822296593
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90440
- **FILM NUMBER:** 251035117

**BUSINESS ADDRESS:**
- **STREET 1:** 520 BROAD STREET
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07120
- **BUSINESS PHONE:** 212-658-1450

**MAIL ADDRESS:**
- **STREET 1:** 520 BROAD STREET
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07120
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JONAS HOWARD S
- **CENTRAL INDEX KEY:** 0001034247
- **STANDARD INDUSTRIAL CLASSIFICATION:** UNKNOWN SIC - 0000 [0000]

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 5)**

**Rafael Holdings, Inc.**

*(Name of Issuer)*

**Class B Common Stock, par value $0.01 per share**

*(Title of Class of Securities)*

**75062E106**

*(CUSIP Number)*

**Howard Jonas**<br>520 Broad Street<br>Newark NJ 07102<br>(973) 438-1000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/05/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **75062E106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Howard S. Jonas** | Name of reporting person<br>**Howard S. Jonas** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1727429.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**12961565.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1727429.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**12961565.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**14688994.00** | Aggregate amount beneficially owned by each reporting person<br>**14688994.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**28.4%** | Percent of class represented by amount in Row (11)<br>**28.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class B Common Stock, par value $0.01 per share

**(b) Name of Issuer:**
Rafael Holdings, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
520 Broad Street, Newark, NJ, 07102

This Amendment No. 5 to Schedule 13D (this "Amendment") supplements and amends the information contained in the Schedule 13D originally filed with the Securities and Exchange Commission (the "Commission") on April 12, 2018, as previously amended by Amendment No. 1, thereto filed with the Commission on February 27, 2023, Amendment No. 2, thereto filed with the Commission on August 3, 2023, Amendment No. 3, thereto filed with the Commission on June 18, 2024, and Amendment No. 4, thereto filed with the Commission on September 30, 2024 (as so amended, the "Schedule 13D").  Terms used but not defined herein shall have the meanings ascribed thereto in the Schedule 13D.  This Amendment No. 5 amends Items 3, 4 and 5, as set forth below.

**Item 4. Purpose of Transaction**

Item 4 is hereby amended and supplemented as follows:

On March 25, 2025, Rafael Holdings, Inc. ("Rafael") completed a business combination transaction with Cyclo Therapeutics, Inc. (the "Merger").  In connection with the Merger, Rafael issued approximately 7,132,228 shares of Class B Common Stock.

On June 26 2024, 565,538 shares of Class B Common Stock were transferred from Deborah Jonas, the wife of Mr. Jonas, to the Debbie Y. Jonas 2018 Marital Trust.  Mr. Jonas maintains shared voting and investment control over the shares held by the Debbie Y. Jonas 2018 Marital Trust.

On July 24 2024, 565,538 shares of Class B Common Stock were transferred from the Debbie Y. Jonas 2018 Marital Trust to the Debbie Y. Jonas 2018 Dynasty Trust.  Mr. Jonas maintains shared voting and investment control over the shares held by the Debbie Y. Jonas 2018 Dynasty Trust.

On June 5, 2025, pursuant to a Standby Purchase Agreement, entered into on May 6, 2025 between Rafael and Mr. Jonas, in connection with a rights offering by Rafael announced on April 29, 2025, certain affiliates, and parties that may be deemed to be affiliates, of Mr. Jonas purchased an aggregate of 16,400,770 shares of Class B Common Stock.  Mr. Jonas has beneficial ownership over 13,080,457 of those shares of Class B Common Stock, as follows: (i) the HSJ 2019 Remainder Trust purchased 12,299,207 shares; (ii) Genie A Partners, L.P. purchased 457,031 shares; and (iii) IDT A Partners, L.P. purchased 324,219 shares.  Under the rights offering, Rafael stockholders received one subscription right (representing the right to purchase 0.526 of a share of Class B Common Stock at $1.28 per share) for each share of Class A Common Stock or Class B Common Stock held of record as of May 9, 2025.  The rights offering provided for a total offering amount of $25.0 million. Mr. Jonas committed to purchasing any unsubscribed shares in a private placement at the same price.

Through his role as manager of the general partner of each of Genie A Partners, L.P. and IDT A Partners, L.P., Howard Jonas has sole voting and dispositive power over the shares of Class B Common Stock held by Genie A Partners, L.P. and IDT A Partners, L.P.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Items 5 is hereby amended by deleting it in its entirety and substituting the following therefor:

As of the date hereof, Mr. Jonas beneficially owns 14,688,994 shares of the Company's Class B Common Stock consisting of: (i) 787,163 shares of Class A Common Stock (which are included herein because they are convertible into the Company's Class B common stock on a one-for-one basis) held by Rafael A Partners, L.P.; (ii) 12,299,207 shares of Class B Common Stock held by the HSJ 2019 Remainder Trust; (iii) 457,031 shares of Class B Common Stock held by Genie A Partners, L.P.; (iii) 324,219 shares of Class B Common Stock held by IDT A Partners, L.P.; (iv) 563,538 shares of Class B Common Stock held by the Debbie Y. Jonas 2018 Dynasty Trust; (v) 159,016 restricted shares of Class B Common Stock held by Mr. Jonas directly, of which 119,262 shares are not subject to contractual restrictions, and 39,754 unvested restricted shares are scheduled to vest on June 13, 2025; and (vi) 98,820 shares of Class B Common Stock held by The Jonas Foundation.

Mr. Jonas' beneficial ownership represents approximately 29.2% of the issued and outstanding shares and 50.9% of the combined voting power of the Company's outstanding capital stock (assuming conversion of all shares of Class A Common Stock into shares of Class B Common Stock), based on 787,163 shares of Class A Common Stock and 50,879,164 shares of Class B Common Stock issued and outstanding as of June 9, 2025 (including shares issued pursuant to the Standby Purchase Agreement).

**(b)**
This filing relates to shares that are owned directly by the Reporting Person, shares that are beneficially owned by the Reporting Person, and shares that are owned by trusts and other entities that are for the benefit of the Reporting Person's children or where the Reporting Person and such children hold the pecuniary interests in the shares. In certain instances, Howard Jonas may be in a position to influence voting or dispositive decisions notwithstanding his having no legal or formal voting or dispositive control over the shares.

This filing identifies Howard S. Jonas as having joint control, including the power to cast or direct the casting of one-tenth of a vote per share, as well as to dispose or direct the disposition of such shares, over the following shares: (i) 12,299,207 shares of Class B Common Stock held by the HSJ 2019 Remainder Trust, of which Peak Trust Company - NV serves as trustee; (ii) 563,538 shares of Class B Common Stock held by the Debbie Y. Jonas 2018 Dynasty Trust, of which Shmuel Jonas and Peak Trust Company - NV serve as co-trustees; and (iii) 98,820 shares of Class B Common Stock held by The Jonas Foundation, of which Mr. Jonas and his wife, Deborah Jonas, serve as co-trustees.

As used herein, the term "beneficially owns" shall be construed as defined by Rule 13d-3 promulgated under the Securities Exchange Act of 1934.

**(c)**
Except as described herein, no transactions in the Class B Common Stock were effectuated by the Reporting Person during the 60 days prior to the date of this Amendment.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Howard S. Jonas

**Signature:** /s/ Joyce J. Mason

**Name/Title:** Joyce J. Mason/Attorney in Fact

**Date:** 06/09/2025